NCT01373554 - Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

October 31, 2013

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

DRUG

Placebo

30mig/bid or 60mg/bid P.O

DRUG

Oltipraz

30mig/bid or 60mg/bid P.O

Trial Locations (5)

Inje University Ilsan Paik Hospital, Dahwa-dong, Ilsanseo-gu

NHUS Ilsan Hospital, Ilsan-ro Ilsan-donggu

Seoul National University Hospital, Daehak-ro Jongno-gu

Korea University Guro hospital, Gurodong-ro

Boramae Hospital, Sindaebang-dong Dongjak-gu